Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).

Huang H, Young W, Chen L, Feng S, Zoubi ZMA, Sharma HS, Saberi H, Moviglia GA, He X, Muresanu DF, Sharma A, Otom A, Andrews RJ, Al-Zoubi A, Bryukhovetskiy AS, Chernykh ER, Domańska-Janik K, Jafar E, Johnson WE, Li Y, Li D, Luan Z, Mao G, Shetty AK, Siniscalco D, Skaper S, Sun T, Wang Y, Wiklund L, Xue Q, You SW, Zheng Z, Dimitrijevic MR, Masri WSE, Sanberg PR, Xu Q, Luan G, Chopp M, Cho KS, Zhou XF, Wu P, Liu K, Mobasheri H, Ohtori S, Tanaka H, Han F, Feng Y, Zhang S, Lu Y, Zhang Z, Rao Y, Tang Z, Xi H, Wu L, Shen S, Xue M, Xiang G, Guo X, Yang X, Hao Y, Hu Y, Li J, Ao Q, Wang B, Zhang Z, Lu M, Li T.

Cell Transplant. 2018 Feb;27(2):310-324. doi: 10.1177/0963689717746999.

2.

Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin.

Siniscalco D, Trotta MC, Brigida AL, Maisto R, Luongo M, Ferraraccio F, D'Amico M, Di Filippo C.

Biology (Basel). 2018 Jan 11;7(1). pii: E10. doi: 10.3390/biology7010010.

3.

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.

4.

Induced pluripotent stem cells as a cellular model for studying Down Syndrome.

Brigida AL, Siniscalco D.

J Stem Cells Regen Med. 2016 Nov 29;12(2):54-60. eCollection 2016. Review.

5.

Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.

Inga Jácome MC, Morales Chacòn LM, Vera Cuesta H, Maragoto Rizo C, Whilby Santiesteban M, Ramos Hernandez L, Noris García E, González Fraguela ME, Fernandez Verdecia CI, Vegas Hurtado Y, Siniscalco D, Gonçalves CA, Robinson-Agramonte ML.

Behav Sci (Basel). 2016 Dec 14;6(4). pii: E29.

6.

Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder.

Siniscalco D.

Front Psychiatry. 2015 Oct 8;6:145. doi: 10.3389/fpsyt.2015.00145. eCollection 2015. No abstract available.

7.

Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.

Antonucci N, Cirillo A, Siniscalco D.

Case Rep Psychiatry. 2015;2015:325061. doi: 10.1155/2015/325061. Epub 2015 Sep 29.

8.

Daily Oxygen/O₃ Treatment Reduces Muscular Fatigue and Improves Cardiac Performance in Rats Subjected to Prolonged High Intensity Physical Exercise.

Di Filippo C, Trotta MC, Maisto R, Siniscalco D, Luongo M, Mascolo L, Alfano R, Accardo M, Rossi C, Ferraraccio F, D'Amico M.

Oxid Med Cell Longev. 2015;2015:190640. doi: 10.1155/2015/190640. Epub 2015 Jul 21.

9.

Inhibition of ocular aldose reductase by a new benzofuroxane derivative ameliorates rat endotoxic uveitis.

Di Filippo C, Zippo MV, Maisto R, Trotta MC, Siniscalco D, Ferraro B, Ferraraccio F, La Motta C, Sartini S, Cosconati S, Novellino E, Gesualdo C, Simonelli F, Rossi S, D'Amico M.

Mediators Inflamm. 2014;2014:857958. doi: 10.1155/2014/857958. Epub 2014 Nov 11.

10.

Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Rossi F, Perrotta S, Bellini G, Luongo L, Tortora C, Siniscalco D, Francese M, Torella M, Nobili B, Di Marzo V, Maione S.

Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12.

11.
12.

Mesenchymal stem cells in treating autism: Novel insights.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173. Review.

13.

The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.

Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N.

J Neuroinflammation. 2014 Apr 17;11:78. doi: 10.1186/1742-2094-11-78.

14.

Perspectives on the use of stem cells for autism treatment.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Review.

15.

Epigenetic findings in autism: new perspectives for therapy.

Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N.

Int J Environ Res Public Health. 2013 Sep 11;10(9):4261-73. doi: 10.3390/ijerph10094261. Review.

16.

Antibodies against food antigens in patients with autistic spectrum disorders.

de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, Abbadessa S, Medici N, Lammers KM, Schiraldi C, Iardino P, Marotta R, Tolone C, Fasano A, Pascotto A, Bravaccio C.

Biomed Res Int. 2013;2013:729349. doi: 10.1155/2013/729349. Epub 2013 Aug 1.

17.

Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.

Siniscalco D, Bradstreet JJ, Antonucci N.

Front Immunol. 2013 Jun 10;4:140. doi: 10.3389/fimmu.2013.00140. eCollection 2013.

18.

Role of neurotrophins in neuropathic pain.

Siniscalco D, Giordano C, Rossi F, Maione S, de Novellis V.

Curr Neuropharmacol. 2011 Dec;9(4):523-9. doi: 10.2174/157015911798376208.

19.

Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N.

J Biomed Biotechnol. 2012;2012:480289. doi: 10.1155/2012/480289. Epub 2012 Feb 13. Review.

20.

Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice.

Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, Maione S.

Front Integr Neurosci. 2011 Dec 1;5:79. doi: 10.3389/fnint.2011.00079. eCollection 2011.

Supplemental Content

Loading ...
Support Center